Lori Goldstein
Medical Oncology · Philadelphia, PANPI 1598735219
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $103,768 of the $128,163 with a category attached, or 81.0%. 14 manufacturers reported payments, led by Daiichi Sankyo Inc. at 44.4% of the total. Reporting peaked in 2019 at $47,917 and has fallen 92.5% since, to $3,596 in 2025. Among medical oncology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $1490.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$57K
- Mylan Inc.$15K
- Merck$10K
- AstraZeneca$8K
- Gilead$6K
- Immunomedics, Inc.$6K
- plus $26K from 8 others
Across 28 payments — averaging $9860.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$274K
- Dompe US, Inc.$2K
What the payments were for
- Consulting fees$103,76881%
- Speaking & faculty fees$12,20810%
- Grants$3500%
- Travel & lodging$10,4218%
- Food & beverage$1,3921%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 33 | $56,913 |
| Mylan Inc. | 11 | $15,288 |
| Merck | 8 | $10,329 |
| AstraZeneca | 4 | $7,910 |
| Gilead | 9 | $5,964 |
| Immunomedics, Inc. | 1 | $5,638 |
| Genentech USA, Inc. | 5 | $5,099 |
| Genentech, Inc. | 6 | $4,369 |
| Eisai CO., LTD. | 2 | $3,915 |
| GE HealthCare | 1 | $3,738 |
| Radius Health, Inc. | 2 | $3,650 |
| Amgen | 1 | $3,300 |
| Eisai Inc. | 2 | $2,000 |
| Pfizer | 1 | $52 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$128,163 in reported general payments places this provider in the 90th percentile of 238 medical oncology providers in Pennsylvania.
Other medical oncology in Philadelphia
- Carl JunePhiladelphia$9M
- Shayma KazmiPhiladelphia$619K
- Marcia BrosePhiladelphia$260K
- Adam CohenPhiladelphia$239K
- Daniel HallerPhiladelphia$227K
- Edith MitchellPhiladelphia$220K
- Elizabeth PlimackPhiladelphia$190K
- Alexander PerlPhiladelphia$176K
- Martin EdelmanPhiladelphia$157K
- Jean-Pierre IssaPhiladelphia$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.